Calcium channel blockers and β-blockers in relation to Parkinson’s disease

We investigated the risk of PD associated with calcium channel blockers (CCBs) and β-blockers in a population-based case-control study of 206 men and women between ages 35 and 89 with a new diagnosis of idiopathic PD between 1992 and 2002, and 383 controls without PD or other neurodegenerative disor...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Ton, Thanh G.N., Heckbert, Susan R., Longstreth, W.T., Rossing, Mary Anne, Kukull, Walter A., Franklin, Gary M., Swanson, Phillip D., Smith-Weller, Terri, Checkoway, Harvey
Format: Artigo
Jezik:Inglês
Izdano: 2006
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1893113/
https://ncbi.nlm.nih.gov/pubmed/17055323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.parkreldis.2006.08.011
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items